I'm sitting here listening to Dr. Yo's interview with
I'm sitting here listening to Dr. Yo's interview with Sarah's husband and I am just in shock about the care systems and drugs. Her husband just said that they gave them the news that there was no hope and basically go home and deal with end of life issues. He discovered and started researching Linronlimab and were told with Corona it was too dangerous for her to do the things she wanted to do to be treated.
Here is a young woman, dying, and she and her husband looking for possible solutions to give them hope and told you can't do this because its dangerous?
The drug/care protocol has to be changed. If I am terminal and I want to try something, that should be a decision between me, my medical professional but when I say this is what I want, it should be the end of the discussion and not require some paper pushing bureaucrat that has to cover their behind. I'd even try to get the drug under the table if I had to.
My heart goes out to this family and I truly hope that Lironlimab can improve her quality and give her quantiy of life too.
5
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Shattering Records: CME Group's Latest Milestone Well, here's a juicy nugget for your investment playbook. On September 4, 2026, CME Group proved, once again, why they're the big dog in the derivatives yard, announcing a new record in FX open interest—4,410,167 contracts! This tops the previous mark of 4,269,622 contracts set just a few months back. The futures and...
Continue Reading
Young Creators Explore Nature Through a New Lens Pontremoli, Italy just became the backdrop for an extraordinary gathering of young visionaries. From August 31 to September 5, UNESCO’s Man and the Biosphere (MAB) Programme and vivo wrapped their 2026 Capture the Future initiative in the lush landscapes of the Appennino Tosco Emiliano Biosphere Reserve. It’s one thing...
Continue Reading
Allegations Stir the Pot: York Space Systems Under Fire Now we're sailing into choppy waters with York Space Systems (YSS). There's a full-blown ruckus stirring as investors take aim at the company, thanks to a class action lawsuit alleging securities fraud. The legal beagles from Glancy Prongay Wolke & Rotter LLP are spearheading this effort, claiming that York pulled...
Continue Reading
Kickstart into a Faith-Fueled Tale Out of Lillington, N.C. comes a novel that isn't just pages of printed text, but almost a life lesson wrapped in fiction. Lee Jennings serves up "Home in Montana," a Christian romance mystery that throws a kaleidoscope of emotions onto the reader's lap, whether they're relaxed in a recliner or flipping through it on their lunch break....
Continue Reading
New Payment Option Brings Flexibility Seems like Six Flags isn't just about roller coasters anymore—now they're playing the long game with wallet-friendly options. Flex Pay by Upgrade is the latest spin on season pass financing, letting guests divvy up payments and kickstart their amusement park fun right away. This move could be a game-changer for folks looking to lock...
Continue Reading
Nurminen Logistics Betting Big on Rail Expansion Feeling the pulse of the logistics world is much like trying to catch lightning in a bottle, but Nurminen Logistics seems to have found its rhythm. They're ramping up their services between Sweden and Italy, leveraging rail to push the envelope. Come October, they're doubling down from one to two weekly departures, giving...
Continue Reading
A new chapter is unfolding in the skies over the Atlantic. La Compagnie is gearing up to connect New York to Düsseldorf with a direct, all-business-class flight starting in Spring 2027. This move is ambitious, tapping into the bustling economic energy present across the North Rhine-Westphalia region—an economic powerhouse littered with U.S.-affiliated businesses. A...
Continue Reading
Automotive ECUs Under the Spotlight Picture this: By 2033, the automotive ECU market is expected to balloon to a whopping $160.59 billion. That's some serious cash, and it ain't just pocket change. This $47 billion jump from 2026 isn't just happening by accident—it's got everything to do with high-octane changes in the industry. With a 5.1% CAGR, you best believe it's a...
Continue Reading
Rewriting the Playbook in Global Skincare AXIS-Y decided to do things their way, not just because they could afford to, but because they believed in their vision. Their strategy defies the trends-driven tactics of this cutthroat beauty world. Instead, they’ve been all about climate-inspired products and vegan, cruelty-free standards. And now, after notching up some...
Continue Reading
New Leadership Steers Strategic Growth Just when you thought the subscription game couldn't get more interesting, in steps Janesh Janardhanan. Frost & Sullivan, the big brain of analytics and growth advice, has handed him the reins of their fancy subscriptions portfolio. Janardhanan's job? To pump some muscle into their global growth and ensure their analytics and...
Continue Reading
Top 5 Most Recently Viewed Articles
Introduction to StaminUp Male Enhancement Gummies Health and wellness are vital aspects of life, and finding the right supplement can make all the difference. StaminUp Male Enhancement Gummies have emerged as an exciting option for those looking to boost their overall health and vitality. Available primarily online, these gummies are attracting attention in various...
Continue Reading
Investors shifted their gaze back to China around 2024 as the country grappled with a slowdown that sent shockwaves through global markets. This wasn’t some knee-jerk reaction; it was a calculated move driven by Beijing's efforts to breathe life into its economy. As global markets continued their wobbly dance, the thought of undervalued Chinese stocks began to captivate...
Continue Reading
EssilorLuxottica's Extended Collaboration with Meta EssilorLuxottica is thrilled to share the news of its strengthened partnership with Meta Platforms. This strategic initiative is aimed at advancing the development of smart eyewear as we head into the next decade. It reflects the dedication both companies have toward innovation in the eyewear industry. A Significant...
Continue Reading
Revolutionizing Hormone Therapy with ProRx Pharma Imagine a world where hormone replacement therapy is as simple as taking a daily pill. ProRx Pharma is making this a reality with the launch of their groundbreaking oral testosterone. This innovative product provides a needle-free option that allows healthcare providers to extend hormone therapy effectively and...
Continue Reading
Datasea Navigates the Compliance Labyrinth Every now and then, a company dares to shake up conventional tech waters, and this time, it's Datasea Intelligent Technology Ltd. At the heart of it, they're pushing an acoustic brain-computer interface (BCI) product toward the U.S. FDA's gates. Ambitious? Sure seems so. But ambitiously clever too, if they play their cards right....
Continue Reading